RV001V, a RhoC Anticancer Vaccine, Against Metastasis From Solid Tumours
Clinical trial NCT03199872 · COMPLETED
Trial details
- NCT number
- NCT03199872
- Sponsor
- RhoVac APS
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-30
- Primary completion
- 2018-08-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.